Cormorant Asset Management

Cormorant Asset Management as of Sept. 30, 2016

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 84 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alder Biopharmaceuticals 6.1 $55M 1.7M 32.77
Nevro (NVRO) 5.7 $51M 491k 104.39
Theravance Biopharma (TBPH) 4.5 $41M 1.1M 36.24
Minerva Neurosciences 4.4 $40M 2.8M 14.12
Proteostasis Therapeutics In 4.0 $37M 2.4M 15.59
Clearside Biomedical (CLSD) 3.8 $35M 2.0M 17.35
Eagle Pharmaceuticals (EGRX) 3.5 $32M 456k 70.00
Heron Therapeutics (HRTX) 3.4 $31M 1.8M 17.23
Ardelyx (ARDX) 3.0 $27M 2.1M 12.94
Myokardia 2.9 $26M 1.6M 16.34
Clovis Oncology 2.6 $23M 650k 36.05
Aclaris Therapeutics (ACRS) 2.5 $23M 901k 25.61
Quotient 2.4 $22M 2.8M 7.82
Galapagos Nv- (GLPG) 2.4 $21M 334k 64.19
Macrogenics (MGNX) 2.3 $21M 708k 29.91
Neurocrine Biosciences (NBIX) 2.2 $20M 398k 50.64
Omeros Corporation (OMER) 2.1 $19M 1.7M 11.16
Protagonist Therapeutics (PTGX) 1.9 $17M 800k 21.13
Wave Life Sciences (WVE) 1.8 $17M 508k 32.47
Sorrento Therapeutics (SRNE) 1.8 $16M 2.1M 7.74
Coherus Biosciences (CHRS) 1.7 $15M 576k 26.78
China Biologic Products 1.6 $14M 113k 124.48
Corbus Pharmaceuticals Hldgs 1.5 $14M 2.0M 6.79
Portola Pharmaceuticals 1.5 $14M 596k 22.71
Cellectis S A (CLLS) 1.3 $12M 498k 24.08
Agenus 1.2 $11M 1.6M 7.18
Invuity 1.2 $11M 768k 13.72
Advaxis 1.1 $9.8M 921k 10.69
Gemphire Therapeutics 1.1 $9.8M 900k 10.92
Contrafect 1.1 $9.5M 3.8M 2.48
Inc Resh Hldgs Inc cl a 1.0 $8.9M 200k 44.58
Blueprint Medicines (BPMC) 1.0 $8.9M 299k 29.70
Dex (DXCM) 1.0 $8.8M 100k 87.66
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.0 $8.8M 456k 19.26
Alnylam Pharmaceuticals (ALNY) 0.9 $8.5M 126k 67.78
Achillion Pharmaceuticals 0.9 $8.1M 1.0M 8.10
Audentes Therapeutics 0.9 $8.0M 450k 17.81
Emergent BioSolutions (EBS) 0.9 $7.9M 250k 31.53
Ultragenyx Pharmaceutical (RARE) 0.9 $7.9M 111k 70.94
Array BioPharma 0.9 $7.8M 1.2M 6.75
Fulgent Genetics (FLGT) 0.8 $7.4M 800k 9.22
Forward Pharma A/s 0.8 $7.1M 339k 21.00
Sangamo Biosciences (SGMO) 0.7 $6.5M 1.4M 4.63
Curis 0.7 $6.3M 2.4M 2.61
Zynerba Pharmaceuticals 0.7 $6.3M 481k 13.05
Recro Pharma 0.7 $5.9M 669k 8.84
Dermira 0.6 $5.8M 172k 33.82
Cytomx Therapeutics (CTMX) 0.6 $5.8M 372k 15.68
Pfenex 0.6 $5.7M 633k 8.95
Avexis 0.6 $5.4M 132k 41.21
Catabasis Pharmaceuticals 0.5 $4.9M 800k 6.16
Intec Pharma 0.5 $4.8M 810k 5.88
Acceleron Pharma 0.5 $4.6M 128k 36.19
Oncobiologics 0.5 $4.4M 1.0M 4.25
Rigel Pharmaceuticals 0.5 $4.2M 1.2M 3.67
Lion Biotechnologies 0.5 $4.2M 506k 8.23
Atara Biotherapeutics 0.4 $4.0M 187k 21.39
Agile Therapeutics 0.4 $3.9M 564k 6.98
Syndax Pharmaceuticals (SNDX) 0.4 $3.6M 240k 15.16
Corvus Pharmaceuticals (CRVS) 0.4 $3.5M 214k 16.45
Lipocine 0.4 $3.4M 751k 4.46
Immune Design 0.4 $3.3M 433k 7.58
Aptose Biosciences 0.2 $2.2M 991k 2.25
Regenxbio Inc equity us cm (RGNX) 0.2 $2.2M 157k 14.01
Glycomimetics (GLYC) 0.2 $2.1M 287k 7.15
Aquinox Pharmaceuticals 0.2 $2.0M 152k 13.36
Celyad Sa 0.2 $1.8M 76k 23.59
Epizyme 0.2 $1.6M 160k 9.84
Ascendis Pharma A S (ASND) 0.1 $1.3M 62k 20.10
Amicus Therapeutics (FOLD) 0.1 $1.1M 152k 7.40
AVEO Pharmaceuticals 0.1 $968k 1.1M 0.89
Nanostring Technologies (NSTGQ) 0.1 $809k 41k 19.98
Threshold Pharmaceuticals 0.1 $688k 1.0M 0.68
Oncobiologics Inc *w exp 05/18/201 0.1 $500k 417k 1.20
Genvec 0.1 $467k 1.0M 0.46
Htg Molecular Diagnostics 0.1 $472k 204k 2.32
Neos Therapeutics 0.0 $333k 51k 6.58
Provectus Biopharmaceuticals I (PVCT) 0.0 $223k 2.2M 0.10
Applied Genetic Technol Corp C 0.0 $169k 17k 9.76
Adaptimmune Therapeutics (ADAP) 0.0 $178k 25k 7.03
Cellectar Biosciences 0.0 $145k 54k 2.70
Oncobiologics Inc *w exp 02/18/201 0.0 $200k 417k 0.48
Provectus Biopharmaceuticals *w exp 06/24/202 0.0 $110k 2.2M 0.05
Cellectar Biosciences Equity Warrants *w 0.0 $13k 53k 0.25